May. 11 at 9:54 AM
$BTBD BARK has some similarities with this stock, so it could work as a study case. BARK received two buyout offers, which reversed its downtrend, until both were rejected by its management.
Then, the stock price didn't just went back to its previous lows, but much lower. And that, despite the management announced huge expenses cuts and positive developments.
The only advantage of BTBD is its nanocap status. It could easily reverse, if a strong catalyst appears, or if the short interest been too high.
BARK started to stabilize after the positive prospects, while the investors wait to see the quarter's results.
